ad

banner image

WpMag

banner image

GLP-1 Weight Loss Drugs: The Future of Obesity Treatment in 2025

 Weight management is changing in a new way.



  • Reduce hunger
  • Stomach contents take more time to be released 
  • Improve the ability of the pancreas to release insulin.
  • Reduce the amount of glucagon that is released by the body

Promoting weight loss as a benefit of GLP-1 Drugs

In a recent clinical trial published in The New England Journal of Medicine, people using semaglutide and tirzepatide lost about 15-20% of their body weight in 12 to 18 months.

  • Better control of sugar in the blood
  • Lesser chance of getting heart disease
  • Changes in metabolic values

1. Ozempic (Semaglutide)Weekly injection 2.
3. Mounjaro (Tirzepatide)


For Weight Loss :  

  • Nausea 
  • Vomiting
  • Vomiting 
  • Diarrhea or problems with constipation
  • Fatigue
  • A person may not feel hungry or may eat less.
  • Even though these conditions are not common, they can lead to serious illness.
  • Pancreatitis
  • Gallbladder disease
  • Researchers have found thyroid tumors in animal experiments.
  • Kidney complications

Ideal Candidates:

  • Those who have found it difficult to use conventional weight loss approaches
  • Those with diabetes who wish for better control of blood sugar
  • People who go here should have certain experiences.
  • Pregnant and breastfeeding mothers
  • People who have undergone medullary thyroid carcinoma
  • Those with serious problems in the gastrointestinal system

  • Leafy greens
  • Omega-3 rich kinds of fish
  • Legumes and oats that contain plenty of fiber

Lifestyle Tips:

 
For Weight Loss : 

Dr. Robert Kushner is a specialist at Northwestern University in treating obesity.

GLP-1 Weight Loss Drugs: The Future of Obesity Treatment in 2025 GLP-1 Weight Loss Drugs: The Future of Obesity Treatment in 2025 Reviewed by THE WELLNESS DOSE on June 10, 2025 Rating: 5

No comments:

Powered by Blogger.